tiprankstipranks
Trending News
More News >
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market

Ensysce Biosciences (ENSC) Income Statement

Compare
289 Followers

Ensysce Biosciences Income Statement

Last quarter (Q3 2025), Ensysce Biosciences's total revenue was $493.10K, a decrease of -85.58% from the same quarter last year. In Q3, Ensysce Biosciences's net income was $-3.73M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.21M$ 2.23M$ 2.52M$ 3.53M$ 3.93M
Gross Profit
$ -2.01M$ -5.36M$ -17.31M$ 3.53M$ 3.93M
Operating Expenses
$ 4.72M$ 5.36M$ 6.91M$ 23.40M$ 5.54M
Depreciation and Amortization
$ 4.00$ -3.00$ 151.00$ 151.00$ 201.00
EBITDA
$ -6.73M$ -10.72M$ -24.22M$ -25.93M$ 834.82K
Operating Income
$ -6.73M$ -10.72M$ -24.22M$ -19.87M$ -1.61M
Other Income/Expenses
$ -1.26M$ 91.91K$ 14.41K$ -9.28M$ 1.45M
Pretax Income
$ -7.99M$ -10.63M$ -24.21M$ -29.15M$ -160.88K
Net Income
$ -7.99M$ -10.61M$ -24.17M$ -29.08M$ 56.77K
Per Share Metrics
Basic EPS
$ -4.57$ -4.69$ -139.44$ -355.68$ 0.56
Diluted EPS
$ -4.57$ -4.69$ -139.44$ -355.68$ 0.56
Weighted Average Shares Outstanding
1.75M 2.26M 179.93K 84.02K 4.46M
Weighted Average Shares Outstanding (Diluted)
1.75M 2.26M 179.93K 84.02K 6.37M
Currency in USD

Ensysce Biosciences Earnings and Revenue History